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Abstract
Background: Systematic reviews (SRs) are considered an important tool for decision-making. There has been no 
recent comprehensive identification or description of child-relevant SRs. A description of existing child-relevant SRs 
would help to identify the extent of available child-relevant evidence available in SRs and gaps in the evidence base 
where SRs are required. The objective of this study was to describe child-relevant SRs from the Cochrane Database of 
Systematic Reviews (CDSR, Issue 2, 2009).
Methods: SRs were assessed for relevance using pre-defined criteria. Data were extracted and entered into an 
electronic form. Univariate analyses were performed to describe the SRs overall and by topic area.
Results: The search yielded 1666 SRs; 793 met the inclusion criteria. 38% of SRs were last assessed as up-to-date prior 
to 2007. Corresponding authors were most often from the UK (41%). Most SRs (59%) examined pharmacological 
interventions. 53% had at least one external source of funding. SRs included a median of 7 studies (IQR 3, 15) and 679 
participants (IQR 179, 2833). Of all studies, 48% included only children, and 27% only adults. 94% of studies were 
published in peer-reviewed journals. Primary outcomes were specified in 72% of SRs. Allocation concealment and the 
Jadad scale were used in 97% and 25% of SRs, respectively. Adults and children were analyzed separately in 12% of SRs 
and as a subgroup analysis in 14%. Publication bias was assessed in only 14% of SRs. A meta-analysis was conducted in 
68% of SRs with a median of 5 trials (IQR 3, 9) each. Variations in these characteristics were observed across topic areas.
Conclusions: We described the methodological characteristics and rigour of child-relevant reviews in the CDSR. Many 
SRs are not up-to-date according to Cochrane criteria. Our study describes variation in conduct and reporting across 
SRs and reveals clinicians' ability to access child-specific data.
Background
Systematic reviews (SRs) are considered the most com-
prehensive tool for decision-making by practitioners, pol-
icy-makers, and consumers. Systematic reviewers aim to
identify all relevant data for a given question and synthe-
size the findings in a rigorous and transparent manner.
The Cochrane Collaboration is identified as "the reliable
source of evidence in healthcare" http://
www.cochrane.org. One of the mechanisms through
which Cochrane SRs are disseminated is the Cochrane
Database of Systematic Reviews (CDSR) which contains
3916 completed SRs covering a broad range of therapeu-
tic interventions (CDSR Issue 3, 2009).
There has been no recent comprehensive identification
or description of the child-relevant SRs contained within
the CDSR. A description of existing child-relevant SRs
would help to identify the extent of available child-rele-
vant evidence available in SRs and gaps in the evidence
base where SRs are required. This may assist with priori-
tization of topics for synthesis within different topic
areas. Further, a description of the methodological
approaches used in child-relevant SRs would provide
information on the rigour and consistency in the conduct
of these reviews.
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We set out to describe child-relevant SRs with respect
to a number of key variables. These efforts provide the
groundwork for other initiatives such as prioritization
activities, methodological research, and ongoing tagging
of child-relevant reviews within the CDSR.
Methods
Definition of child-relevant SR
For the purposes of this project we defined a child-rele-
vant SR as one that intended to include children (0-18
years of age) or studied an intervention intended to
improve the health and well-being of children (e.g., smok-
ing control programs for family and caregivers [1], fam-
ily-centered care for hospitalized children [2], parenting
programs for psychosocial outcomes in adolescents [3]).
Systematic reviews related to pregnancy were excluded
except for studies on breastfeeding or nutritional supple-
ments for the baby during pregnancy. These criteria are
consistent with those of the Cochrane Child Health Field
Trials Register.
Search
A Research Librarian searched all years of the CDSR
(Issue 2, 2009) using a pediatric search filter to identify
child-relevant SRs. The search strategy is listed in Addi-
tional file 1.
Screening
The records that were identified from the search under-
went two phases of screening for inclusion. A screening
algorithm was developed a priori (Additional file 2). One
author screened the titles and abstracts of all reviews and
classified them as "include", "exclude", or "unsure". When
necessary, the full text of the review was retrieved to
assess relevance. The included reviews were further clas-
sified by study population as follows: children (intended
population was only children); children and adults
(intended population was children and adults); unclear
(intended population included children but upper age
limit unclear); pregnancy (topic involved breastfeeding or
nutritional supplements during pregnancy). All reviews
labelled "exclude" were assessed by a second reviewer
(LH) to ensure accuracy in study selection. Any discrep-
ancies were reviewed by a clinician (TK). Reviews
labelled "unclear" were assessed by a second reviewer
(LH) to determine relevance to child health. Those that
remained unclear were reviewed by a clinician (TK) who
made the final decision regarding inclusion.
Data extraction
We developed and pilot tested an electronic form for data
extraction (form available from corresponding author on
request). Data were extracted and entered directly onto
the electronic form using Microsoft Excel. The variables
extracted fell into three main categories: general charac-
teristics (publication dates, country of corresponding
authors, nature of interventions, external source of fund-
ing); characteristics of included studies (study designs
sought and included, number of studies and participants,
ages represented in primary studies, whether or not
included studies were published in peer-reviewed jour-
nals); and methodological approaches (whether authors
specified a primary outcome, approach to methodologi-
cal quality assessment, approach to analysis, whether
meta-analyses were conducted, proportion of trials [and
reports] contributing to the largest meta-analysis,
whether publication bias was assessed).
The country of corresponding authors was classified on
indices of human development (high, medium or low as
defined by the United Nations [http://hdr.undp.org/en/
statistics/, accessed July 2009]) and income level (high,
upper-middle, lower-middle, or low income according to
the World Bank [http://web.worldbank.org/WBSITE/
EXTERNAL/DATASTATISTICS/0,,content-
MDK:20421402~pagePK:64133150~piPK:64133175~the
SitePK:239419,00.html, accessed July 2009]). The nature
of the interventions under comparison was classified as
pharmacological or non-pharmacological based on a def-
inition provided by Health Canada (http://www.hc-
sc.gc.ca/dhp-mps/prodpharma/databasdon/terminolog-
eng.php, accessed May 2009). Standard definitions were
used to classify interventions as a natural health product
(http://www.hc-sc.gc.ca/dhp-mps/prodnatur/index-
eng.php, accessed June 2009) or a device (http://
www.fda.gov/CDRH/DEVADVICE/312.html, accessed
June 2009). Studies were classified as children only (all
participants < 18 years of age), adult only (all participants
> = 18 years of age), or mixed.
Data analysis
Univariate analyses were conducted to describe the SRs
and the primary studies they contained. The data were
analyzed overall and within each of the relevant
Cochrane Review Groups (CRG) from among The
Cochrane Collaboration's 52 CRGs. Data were presented
separately for CRGs containing more than 25 child-rele-
vant reviews.
Results
Of the 3916 completed reviews in the CDSR, 1666 were
identified through the search as potentially relevant to
child health. Overall, 1046 met the inclusion criteria (Fig-
ure 1), and were included across 38 CRGs. The CRGs
with the largest number of child-relevant reviews were:
Neonatal (n = 253 representing 24% of all child-relevant
reviews), Airways (n = 118; 11%), Acute Respiratory
Infections (n = 70; 7%), Cystic Fibrosis and Genetic Dis-
orders (n = 66; 6%), Infectious Diseases (n = 58; 5%), and
Developmental, Psychosocial, and Learning problems (nBow et al. BMC Pediatrics 2010, 10:34
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= 49; 5%). Table 1 provides further details of the reviews
by CRG, the proportions with children only and children
and adult populations, and the proportion of child-rele-
vant reviews to all reviews within each CRG. Figure 2
illustrates the increase of child-relevant reviews as a pro-
portion of all reviews in the CDSR from 1998 to 2008. In
the following sections we describe the child-relevant
reviews; neonatal reviews were not included in the analy-
sis as they have recently been described elsewhere [4].
General characteristics of child-relevant reviews 
(Additional file 3)
The median dates of protocol and initial publication
were 2002 and 2004, respectively. The median number of
years between publication of protocol and review was 2
(IQR 1, 3). This varied across review groups, ranging
from 1 year for Cystic Fibrosis and Genetics (IQR 1, 2),
Developmental, Psychosocial, and Learning Problems
(IQR 1, 2) and Injuries (IQR 0, 2) to 3 years (IQR 2, 4) for
Oral Health. The median date for when reviews were 'last
assessed as up-to-date' was 2007; 38% of SRs were last
assessed as up-to-date prior to 2007.
The corresponding authors were most often from the
UK (41.1%) followed by the rest of Europe (14.8%), North
America (14.0%), Australia (14.0%), Asia (8.7%), Africa
(4.9%), and South America (2.5%). The vast majority of
reviews were produced in countries with indices of high
income (85.6%) and high human development (88.4%).
The countries classified as middle and low human devel-
opment were most often represented in reviews pro-
duced by the Infectious Diseases Group.
The majority of reviews examined pharmacological
interventions (59.0%) according to the Health Canada
definition, which included drugs (52.2%), vaccines (3.6%),
or natural health products (8.0%). The largest portion of
non-pharmacological reviews (16.9% of total) consisted
of educational, behavioural, psychological, policy, or leg-
islative interventions. A small proportion of reviews
(6.1%) compared pharmacological and non-pharmaco-
logical interventions. The nature of the intervention var-
ied across CRGs reflecting the different topic areas, e.g.,
the Oral Health, the Developmental, Psychosocial and
Learning Problems, and the Injuries Groups more often
evaluated non-pharmacological interventions.
Approximately half of the reviews (52.5%) had at least
one external source of funding, though many had multi-
ple sources. The Infectious Diseases Group received
external funding for over 90% of their child-relevant
reviews. The most common sources of external funding
were government (48.6%), foundation (15.4%), and
Cochrane (12.6%).
Characteristics of studies included in child-relevant reviews 
(Additional file 4)
The majority of reviews intended to include only ran-
domized controlled trials (RCTs) (54.2%), while some
searched for RCTs and other designs (most often quasi-
RCTs) (45.4%) and very few searched only for non-RCTs
(0.4%). In actuality, 71.6% of reviews included RCTs only,
27.1% included RCTs and other designs, and 1.3%
included only non-RCTs. This varied substantially across
CRGs, reflecting the nature of evidence available across
different topics and types of interventions.
The median number of trials included in a review was 7
(inter-quartile range [IQR]: 3, 15). This varied across
groups ranging from 3 (IQR: 1, 6.75) for Cystic Fibrosis to
10 (IQR: 6, 17.75) for Infectious Diseases. Seventy-four
reviews (9.3%) had no relevant trials. This also varied
between groups, with 2 (2.9%) in Acute Respiratory
Infections to 14 (21.2%) in Cystic Fibrosis.
Figure 1 Flow of systematic reviews through the screening pro-
cess.
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Table 1: Child-relevant reviews by Cochrane Collaborative Review Group (CRG)
Cochrane 
Collaborative Review 
Group
Total completed 
reviews in CDSR
Total child-relevant 
reviews (percent of 
child relevant to all 
completed reviews)
Reviews intending to 
include only children 
(n)
Reviews intending to 
include both children 
and adults (n)
Neonatal 253 253 (100) 252 1
Airways 221 118 (53.4) 36 82
Acute Respiratory 
Infections
102 70 (68.6) 38 32
Cystic Fibrosis and 
Genetic Diseases
80 66 (82.5) 10 56
Infectious Diseases 94 58 (61.7) 9 49
Developmental, 
Psychosocial and 
Learning Problems
73 49 (67.1) 36 13
Oral Health 92 32 (33.7) 18 14
Epilepsy 50 30 (60.0) 6 24
Ear, Nose and Throat 
Disorders
55 28 (50.9) 12 16
Injuries 93 26 (28.0) 7 19
Pregnancy and 
Childbirth
359 26 (7.2) 1 25
Renal 74 22 (29.7) 8 14
HIV/AIDS 57 22 (38.6) 6 16
Neuromuscular 
Disease
76 21 (27.6) 2 19
Pain, Palliative and 
Supportive Care
113 20 (17.7) 4 16
Inflammatory Bowel 
Disease and Functional 
Bowel Disorders
50 19 (38.0) 3 16
Skin 42 16 (38.1) 4 12
Metabolic and 
Endocrine disorders
67 16 (23.9) 9 7
Anaesthesia 53 16 (30.2) 7 9
Heart 75 14 (18.7) 3 11
Musculoskeletal 117 14 (12.0) 5 9
Incontinence 60 12 (20.0) 8 4
Depression, Anxiety 
and Neurosis
104 12 (11.5) 5 7
Wounds 63 12 (19.0) 1 11
Eyes and Vision 75 10 (13.3) 8 2
Tobacco Addiction 48 9 (18.8) 4 5
Consumers and 
Communication
27 9 (33.3) 3 6
Gynaecological Cancer 68 8 (11.8) 0 8
Hepato-Biliary 107 6 (5.6) 1 5
Drugs and Alcohol 50 5 (10) 3 2
Colorectal Cancer 58 5 (8.6) 0 5Bow et al. BMC Pediatrics 2010, 10:34
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Children-only studies made up approximately half of
the included studies (47.5%). Adult-only studies made up
26.9% of included studies and children-adult mixed stud-
ies made up 14.6%. The remainder of studies did not indi-
cate a mean age or range of ages for participants. The
median number of participants included in each review
was 679 (IQR 179, 2833).
Overall, 9248 of studies (94.6%) included in the reviews
were published in peer-reviewed journals.
Methodological approaches in child-relevant reviews 
(Additional file 5)
Reviewers specified a primary outcome in 72.4% of
reviews. This number varied substantially between
groups, from 26.9% in Injuries to 90.0% in Infectious Dis-
eases.
Allocation concealment was the most common
approach to assessing methodological quality, used in
96.9% of reviews. Among 5171 included studies, alloca-
tion concealment was adequate in 28.8%, inadequate in
7.5% and unclear in 62.2%. The Jadad scale was used in
181 (25.1%) reviews; this also varied substantially from
1.7% in Infectious Diseases to 63.6% in Airways.
C h i l d r e n  w e r e  a n a l y z e d  s e p a r a t e l y  i n  5 2  ( 1 1 . 5 % )
reviews that included both children and adults. Addition-
ally, subgroup analyses for adults and children were per-
formed in 63 (13.9%) reviews. Subgroup analyses were
also performed within children in 35 (5.3%) reviews.
Publication bias was formally assessed in 97 (12.2%)
reviews; it was assessed graphically in 90 (92.8%) and sta-
tistically in 32 (33.0%) reviews. In 158 (22.0%) reviews,
publication bias was mentioned but was not assessed.
The majority of reviews (63.8%) did not mention publica-
tion bias.
Meta-analyses were conducted in 484 reviews (68.3%).
In those reviews that conducted a meta-analysis, a
median of 5 trials were included in the largest meta-anal-
y s i s  c o n d u c t e d  ( I Q R  3 ,  9 ) .  T h e  m e d i a n  p e r c e n t a g e  o f
included studies that contributed to the largest meta-
analysis in each review was 50% (IQR 33, 78).
Discussion
The principal outcome of this study was the characteriza-
tion of child-relevant SRs that are currently available in
t h e  C o c h r a n e  D a t a b a s e  o f  S y s t e m a t i c  R e v i e w s .  T h i s
descriptive analysis provides information on the extent of
evidence synthesis on child-relevant topics as well as
variation in methodological characteristics and rigour
across the reviews. The register compiled through this
effort provides a basis to identify gaps in the evidence
base where reviews or updates are needed and to assist
with prioritization for the production or updating of
reviews within different topic areas. The register will also
help identify priority areas for primary research in chil-
dren. Further, ongoing identification and tagging of child-
r e l e v a n t  S R s  w i l l  f a c i l i t a t e  a c c e s s  t o  p e d i a t r i c - s p e c i f i c
data.
Over the ten years studied, there has been a steady
increase in the number and proportion of child-relevant
reviews in the CDSR. This finding is inconsistent with the
observation that the volume of adult trials is growing at a
faster rate than pediatric trials [5]. One of the key vari-
ables that we extracted was the number of trials within
each child-relevant review that involved children only,
adults only, or mixed adult and children populations. We
found that less than half (47.4%) of studies included in
child-relevant reviews were conducted solely in children.
Moreover, only 25.2% of reviews that included both chil-
dren and adults conducted separate analyses (11.4%) or
subgroup analyses (13.8%) to distinguish between the
results of the two groups. This figure may in part reflect
the fact that separate or subgroup analyses were not
deemed necessary in some situations (e.g., studies involv-
ing older adolescents and adults where there is no devel-
opmental or physiological basis for differences in
response to a particular intervention). The extent of sepa-
Movement Disorders 44 5 (11.4) 2 3
Upper Gastrointestinal 
and Pancreatic 
Diseases
41 5 (12.2) 3 2
Childhood Cancer 3 3 (100) 2 1
Peripheral Vascular 
Diseases
75 3 (4.0) 3 0
Effective Practice and 
Organization of Care
58 2 (3.5) 1 1
Schizophrenia 135 2 (1.5) 1 1
Haematological 20 2 (10.0) 1 1
TOTAL 3916 1046 (26.7) 522 524
Table 1: Child-relevant reviews by Cochrane Collaborative Review Group (CRG) (Continued)Bow et al. BMC Pediatrics 2010, 10:34
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rate or subgroup analyses for children varied across
Review Groups which also may reflect different situations
where there may or may not be reason to expect a differ-
ence in effect. Nevertheless, previous work has suggested
that there may be insufficient evidence specific to chil-
dren for certain topic areas [6]. This is particularly prob-
lematic in situations where the safety and efficacy of
interventions for children may differ from adults due to
variations in developmental physiology, disease
pathophysiology, or developmental pharmacokinetics
and pharmacodynamics [7]. Systematic reviewers should
be considering separate or subgroup analyses for children
and discuss the applicability of the evidence for age
groups that may show differential effects.
Several additional observations can be made regarding
the extent of evidence available for child-relevant
reviews. Overall, 9.3% of reviews found no relevant stud-
ies. This represents an important portion of child-rele-
vant reviews and suggests that there is a need for primary
research in a variety of areas. The proportion of reviews
with no relevant studies varied across Review Groups and
was particularly high (>20%) for the Cystic Fibrosis and
Genetic Disorders and the Developmental, Psychosocial,
and Learning Disorders Groups. Further, the median
number of studies per review was 7 (IQR 3, 15) which is
consistent with an analysis of Cochrane reviews pub-
lished in 2004 [8]. As many authors stated, this often pro-
vides insufficient data to attain significant results in
meta-analyses, conduct subgroup analyses, or assess for
publication bias. Finally, on average only half of relevant
studies contributed to the largest meta-analysis in each
review. Over-reliance on the results of meta-analyses is
problematic as most meta-analyses will reflect only a por-
tion of the available evidence. Research has demonstrated
that the magnitude of effect decreases as the proportion
o f  r e l e v a n t  t r i a l s  c o n t r i b u t i n g  t o  t h e  m e t a - a n a l y s i s
increases [9].
One of the key goals of The Cochrane Collaboration is
to ensure that available evidence is up-to-date http://
www.cochrane.org. To this end, The Cochrane Collabo-
ration has implemented a policy that authors update their
reviews every two years [10]. We found a median date of
2007 for when reviews were 'Last Assessed as Up-to-
Date,' suggesting that the majority of reviews have been
updated according to Cochrane policy. However, 38% of
the relevant reviews were last assessed as up-to-date
prior to 2007 and are therefore considered out-of-date by
Cochrane standards. This proportion varied across
Review Groups. Additionally, 22 of the reviews that we
had originally identified as relevant to the register were
subsequently found to be withdrawn from The Cochrane
Library and could not be included in our analysis. While
there is ongoing work on the appropriate timing of
updates [11-14], mechanisms are needed to ensure that
child-relevant reviews are in fact providing the most up-
to-date accurate information for decision-makers. This
presents a challenge for reviewers in terms of the time
and resources required for updates, as well as the end-
users of the reviews or those wanting to synthesize the
reviews (e.g., in overviews of reviews) as a basis for deci-
sion-making.
A further goal of The Cochrane Collaboration is to be
global in its scope and meet the health information needs
of people worldwide. Consistent with a previous descrip-
tive analysis of SRs published in 2004 [8], we found that
an overwhelming majority of studies had corresponding
authors in countries with a high rating on indices of
human development and income level. This variable is
simply a proxy for the applicability of topics to countries
with different indices of human development and income
level. For instance, many of the reviews with a corre-
sponding author from these countries may in fact be rele-
vant to lower income/development countries and may
also have co-authors from these countries. There was
interesting variation across Review Groups. For example,
authors from the Airways and the Cystic Fibrosis and
Genetic Disorders groups were primarily from high
income regions (UK, Australia, North America) whereas
those in the Acute Respiratory Infections and especially
the Infectious Diseases Groups were more evenly distrib-
uted worldwide, and more often included authors from
Africa and Asia. This likely reflects the conditions of
most interest, and perhaps the highest prevalence, in
developing countries.
Approximately 40% of reviews examined non-pharma-
cological interventions, which is consistent with a sample
of Cochrane reviews published in 2004 [8]. The most fre-
quently examined non-pharmacological interventions
were educational, behavioural, psychological, policy or
legislative interventions. This reflects the usefulness of
reviews within the CDSR to a variety of end-users includ-
ing a range of practitioners and policy-makers. The vari-
ety of interventions examined in reviews may also explain
some of the variability observed in the types of study
designs included.
One of the strengths of The Cochrane Collaboration is
that it includes methodological experts worldwide and
produces cutting-edge methods for the conduct of sys-
tematic reviews. The Cochrane Handbook represents
state of the art systematic review methods [10]. Further,
Cochrane reviews have been found to have better report-
ing quality than paper-based reviews [8,15]. Despite this,
we found substantial variation in the conduct of reviews
across the Review Groups. For example, over 27% of
reviews did not specify a primary outcome and this pro-
portion varied substantially across Review Groups, rang-Bow et al. BMC Pediatrics 2010, 10:34
http://www.biomedcentral.com/1471-2431/10/34
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ing from 10 to 73%. Specification of primary outcomes
should be done at the protocol stage. Peer-reviewed, pub-
lished protocols are required for Cochrane reviews; the
PRISMA group that develops guidelines for the reporting
of systematic reviews is now advocating registration of all
SR protocols to enhance "transparency and accountabil-
ity" [16].
The approach to assessment of methodological quality
also varied across reviews. Allocation concealment was
most commonly assessed; this is consistent with the rec-
ommended Cochrane methods prior to 2008 after which
time the Risk of Bias (RoB) tool was introduced. Despite
long-standing caution against the use of scales for quality
assessment [17], the Jadad scale was often used, particu-
larly within certain Review Groups. Finally, a very small
proportion of reviews assessed for publication bias which
is consistent with a previous sample [8]. Most reviews did
not mention publication bias at any point; however, some
authors stated that an assessment was intended, but was
not done, likely due to an insufficient number of included
studies. Our findings suggest a potential for publication
bias in the reviews, as we found that a high percentage of
the included studies (94.6%) were published in peer-
reviewed journals. Previous research suggests that pub-
lished studies tend to present positive findings. For exam-
ple, in a study of abstracts presented at a major pediatric
research meeting, only 60% were subsequently published
and those published were more likely to report positive
findings [18].
Approximately half of the reviews received no funding
f r o m  e x t e r n a l  s o u r c e s .  T h i s  v a r i e d  s u b s t a n t i a l l y  a c r o s s
review groups, with over 90% of reviews in the Infectious
Diseases Group receiving external funding compared to
only 20% in the Epilepsy Group. The time and resources
required to conduct a methodologically rigorous SR are
substantial. Lack of funding will seriously hamper efforts
to synthesize evidence in child health. While we did not
collect data regarding funding for updates, it is likely that
funding is less frequently available for updating reviews.
This will be an important obstacle to achieving the
Cochrane's mission of ensuring that evidence for deci-
sion-making is up-to-date.
This work provides a solid foundation for future
research in two key areas. F irst, the data we ha ve col-
lected will serve as a baseline to examine changes and
standardization in review methods over time, as well as
the availability of child specific evidence. Second, this
work provides a basis for methodological research inves-
t i g a t i n g  b i a s  a t  t h e  l e v e l  o f  S R s,  a s  w e l l  a s  t r i a l s  ( e . g. ,
through meta-epidemiological methods). Empirical evi-
dence of bias specific to child-relevant research will result
in a better understanding of biases and how they operate
in this context.
Limitations of this study
The main limitation we encountered resulted from
inconsistent or lack of reporting by review authors for key
variables, confirming previous findings that there is room
for improvement in reporting of SRs [15]. For example,
the number of participants included in the reviews was
inconsistently reported. Sometimes the overall number
was reported in the abstract or beginning of the results
section. Other times, the data extractors had to rely on
the information in the Characteristics of Included Studies
table. Review authors did not always specify whether the
number cited corresponded to participants recruited,
randomized, or analyzed. Due to these and other caveats,
the total number of participants cited in our data is likely
smaller than those that were actually included in all
reviews. The other variable that was particularly prob-
lematic was whether the included studies included chil-
dren-only, adult-only, or mixed populations. Often this
detail was not reported for each included study. We used
a strict cut-off of 18 years to differentiate study popula-
tions; therefore, some studies with older adolescents
would be categorized as mixed populations but the actual
participants may be relatively homogeneous in terms of
physiology or development. We chose inclusion criteria
that were consistent with the Cochrane Child Health
Field Trials Register which excludes all pregnancy studies
except those evaluating breastfeeding or nutritional sup-
plements. There are numerous other interventions
administered during pregnancy that may affect infant
outcomes; however, these were not captured in this
descriptive analysis and may be an interesting focus for
future work. Moreover, we may have missed reviews of
interventions that do not directly involve children but are
intended to improve their health.
Conclusions
We have described the evidence available from child-rele-
vant reviews in the CDSR. Children-only studies repre-
s e n t e d  l e s s  t h a n  h a l f  o f  t h e  s t u d i e s  i n c l u d e d  i n  c h i l d -
relevant reviews. There is a need for more evidence spe-
cific to children, particularly when efficacy or safety may
differ across age groups. There is wide variation in meth-
ods across the Cochrane Review Groups. Standardization
in methods based on empirical evidence should be
encouraged. Many reviews are considered out-of-date
according to Cochrane standards. The majority of
reviews were conducted in high income countries, and
therefore may not reflect the health priorities of lower- or
middle-income countries. This information will serve to
inform the conduct and focus of future SRs and primary
research in child health. Moreover, the register compiled
through this effort will serve as a basis for methodological
research to understand biases in reviews and primary
studies.Bow et al. BMC Pediatrics 2010, 10:34
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